Navigation Links
DoseCue(TM) Presents Positive Study Results at BioTech 2009
Date:11/16/2009

PHILADELPHIA, Nov. 16 /PRNewswire/ -- DoseCue, LLC announced this week that medication containers equipped with their automatic dose-time reminder devices significantly increase compliance, or adherence, according to results from a recent study.

The data, which were presented at BioTech 2009 in Philadelphia, showed that DoseCue electronic devices significantly improved patient compliance with oral-dose medications by 9.1%, without adding steps or changing the patient's dose-taking routine. In addition, overall compliance averaged 97.1% in the Study Group in Phase 2.

"This represents an important 'first'," stated DoseCue CEO, Mark Burrows. "The DoseCue trial is the first of its kind to achieve a statistically significant improvement in compliance using this one-of-a-kind, patented technology," he added, noting 95% Confidence Interval.

DoseCue's patented technology is integrated directly into manufacturers' current containers during filling and issues automatic reminder cues to patients when a medication needs to be dosed and signals when the dose has been taken. Electronics are integrated into the medication container itself, not the closure, to avoid mix-up and help differentiate the product.

The DoseCue study was conducted at a retail pharmacy to determine if patient compliance improved when oral-dose medications were dispensed in a DoseCue-equipped container. Thirty-five (35) patients were enrolled and randomized into either a Control or Study Group. All patients used an inactive container for Month 1 (Phase 1) which, unknown to participants, automatically logged date and time of open/close events, after which half were crossed-over to a container which also cued at dose time (Study Group). Remaining patients continued use of the inactive container (Control Group). Twenty-four (24) patients completed the study.

"We know the costs of non-compliance are high," said Burrows. "With DoseCue, there's no guesswork and compliance rates improve, resulting in better disease management, increased sales, and lower costs to the healthcare system."

DoseCue, LLC is a medication compliance company that integrates electronic dose-time reminder cues into manufacturers' existing factory-filled containers. These containers are clinically proven to increase compliance and remove the burden on patients to remember to take their oral-dose medication as prescribed by their physician.

www.dosecue.com

SOURCE DoseCue, LLC


'/>"/>
SOURCE DoseCue, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology news :

1. Frontiers in Optics presents scientific advancements
2. New book presents successful strategies for probing genetic variation
3. NARSAD presents 2007 prizes for outstanding achievement in neuroscience and psychiatric research
4. New book presents methods to poke and prod individual molecules
5. Internationally recognized experts presents a complete overview on hydroecology and ecohydrology
6. Researcher helping to pioneer medical therapy for Fragile X Syndrome presents latest findings
7. ICS presents prestigious Digby McLaren Medal to Cincinnatis Carl Brett
8. Penn presents inaugural symposium on applied mathematics and computational science
9. Soil Science Society of America presents 2008 fellows
10. Soil Science Society of America presents awards in Houston
11. Arbor Vita presents new data on cancer diagnostic at EUrogin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2016)... Jan. 22, 2016 ... of the "Global Biometrics Market in ... offering. --> http://www.researchandmarkets.com/research/p74whf/global_biometrics ) ... "Global Biometrics Market in Retail Sector 2016-2020" ... --> Research and Markets ( http://www.researchandmarkets.com/research/p74whf/global_biometrics ...
(Date:1/20/2016)... A market that just keeps on growing. ... explosion in genomics knowledge. Learn all about it in ... of dynamic trends are pushing market growth and company ... pharmacogenomics - pathogen evolution - next generation sequencing - ... understanding of the role of genetic material in Disease ...
(Date:1/20/2016)... Calif. , Jan. 20, 2016  Synaptics ... of human interface solutions, today announced sampling of ... solution for wearables and small screen applications including ... as printers. Supporting round and rectangular shapes, as ... offers excellent performance with moisture on screen, while ...
Breaking Biology News(10 mins):
(Date:2/5/2016)... , Feb. 5, 2016  In the pharmaceutical ... for a host of launch activities including the identification ... this launch activity is especially high in the oncology ... Best Practices and the Role of Medical Affairs ... companies focused on oncology therapies find better ways to ...
(Date:2/5/2016)... , February 5, 2016 Amarantus ... biotechnology company focused on developing products for Regenerative Medicine, ... Rare Pediatric Disease Designation (RPDD) from the US Food ... with MANF. MANF was previously granted orphan drug designation ... --> Amarantus BioScience Holdings, Inc. (OTCQB: ...
(Date:2/4/2016)... ... February 04, 2016 , ... Morf Media Inc ... an interactive FDA compliance training course, Writing Effective SOPs ... accredited interactive course on Morf Playbook—now conveniently available on smartphones and PCs--provides step ...
(Date:2/4/2016)... 2016  Sangamo BioSciences, Inc. (NASDAQ: SGMO ), ... Edward Lanphier , Sangamo,s president and chief executive ... Sangamo,s ZFP Therapeutic ® development programs and an ... ET on Thursday, February 11, 2016, at the Leerink ... conference is being held in New York ...
Breaking Biology Technology: